Boundless Bio, Inc.
BOLD
$2.83
$0.061.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.69M | -13.56M | -12.89M | -13.88M | -15.68M |
| Total Depreciation and Amortization | 1.26M | 284.00K | 307.00K | 310.00K | 317.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.91M | 1.87M | 1.64M | 1.53M | 1.82M |
| Change in Net Operating Assets | -9.45M | -3.57M | 831.00K | 1.85M | 1.71M |
| Cash from Operations | -20.97M | -14.97M | -10.11M | -10.20M | -11.83M |
| Capital Expenditure | -38.00K | -8.00K | -424.00K | -15.00K | -48.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.11M | 14.60M | 13.40M | 10.49M | 11.34M |
| Cash from Investing | 23.07M | 14.59M | 12.97M | 10.48M | 11.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 73.00K | -- | 24.00K | 0.00 | 117.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 73.00K | -- | 24.00K | 0.00 | 117.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.17M | -385.00K | 2.89M | 283.00K | -420.00K |